

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35476508 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.35476508 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.03082966 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.03082966 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.61193977 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.13423283 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.01537509 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.01537509 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.01537509 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.85615741 |
| 11 | * bile acid biosynthetic process (GO:0006699) | 5.71847989 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.66422429 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.66407882 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56315608 |
| 15 | urea metabolic process (GO:0019627) | 5.45056040 |
| 16 | urea cycle (GO:0000050) | 5.45056040 |
| 17 | cysteine metabolic process (GO:0006534) | 5.43214101 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.38156123 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.37365733 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.36003481 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.34745993 |
| 22 | protein carboxylation (GO:0018214) | 5.29262729 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29262729 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.28964598 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.22280890 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.03500223 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98694836 |
| 28 | regulation of complement activation (GO:0030449) | 4.95744384 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.90717756 |
| 30 | * bile acid metabolic process (GO:0008206) | 4.85137932 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.78075585 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.77560270 |
| 33 | oligosaccharide catabolic process (GO:0009313) | 4.77327631 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.76571271 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.70929024 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.64598929 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.64598929 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64598929 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.58827260 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.58591869 |
| 41 | glycosphingolipid catabolic process (GO:0046479) | 4.57255292 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.55660461 |
| 43 | phospholipid efflux (GO:0033700) | 4.51524458 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.51096936 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.51096936 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.50544389 |
| 47 | lysine catabolic process (GO:0006554) | 4.45684929 |
| 48 | lysine metabolic process (GO:0006553) | 4.45684929 |
| 49 | glycine metabolic process (GO:0006544) | 4.36072442 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.35482062 |
| 51 | imidazole-containing compound metabolic process (GO:0052803) | 4.35133954 |
| 52 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.34805398 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.34750958 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.34750958 |
| 55 | coenzyme catabolic process (GO:0009109) | 4.32130670 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.30547462 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.24285217 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.20358793 |
| 59 | amine catabolic process (GO:0009310) | 4.19718413 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.19718413 |
| 61 | ethanol oxidation (GO:0006069) | 4.19652516 |
| 62 | glycolipid catabolic process (GO:0019377) | 4.15989460 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.14966815 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.11618429 |
| 65 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06555554 |
| 66 | cholesterol efflux (GO:0033344) | 4.05881992 |
| 67 | blood coagulation, intrinsic pathway (GO:0007597) | 4.03014414 |
| 68 | glutamate metabolic process (GO:0006536) | 4.02727135 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 4.00391672 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.97056204 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.96620172 |
| 72 | cellular glucuronidation (GO:0052695) | 3.95217715 |
| 73 | fibrinolysis (GO:0042730) | 3.93056256 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.91704984 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.90024940 |
| 76 | arginine metabolic process (GO:0006525) | 3.87578762 |
| 77 | ceramide catabolic process (GO:0046514) | 3.81742725 |
| 78 | cofactor catabolic process (GO:0051187) | 3.77371638 |
| 79 | protein activation cascade (GO:0072376) | 3.77340278 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75508301 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75508301 |
| 82 | complement activation, classical pathway (GO:0006958) | 3.74272842 |
| 83 | complement activation (GO:0006956) | 3.71795282 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.69206672 |
| 85 | organic acid catabolic process (GO:0016054) | 3.69206672 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68301517 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.66013061 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.65266522 |
| 89 | opsonization (GO:0008228) | 3.65098310 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.63792167 |
| 91 | epoxygenase P450 pathway (GO:0019373) | 3.63276017 |
| 92 | ketone body metabolic process (GO:1902224) | 3.63009973 |
| 93 | cytolysis (GO:0019835) | 3.61723963 |
| 94 | drug catabolic process (GO:0042737) | 3.59941130 |
| 95 | NAD biosynthetic process (GO:0009435) | 3.59514345 |
| 96 | sterol homeostasis (GO:0055092) | 3.58938468 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.58588147 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58254384 |
| 99 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57487077 |
| 100 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57487077 |
| 101 | acetyl-CoA metabolic process (GO:0006084) | 3.56085648 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.55971779 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.55561206 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 3.55180059 |
| 105 | exogenous drug catabolic process (GO:0042738) | 3.53805776 |
| 106 | regulation of cholesterol storage (GO:0010885) | 3.53407693 |
| 107 | barbed-end actin filament capping (GO:0051016) | 3.49878305 |
| 108 | amino sugar catabolic process (GO:0046348) | 3.48860013 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.48742900 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.48742900 |
| 111 | regulation of plasminogen activation (GO:0010755) | 3.46531068 |
| 112 | omega-hydroxylase P450 pathway (GO:0097267) | 3.42118138 |
| 113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.39872928 |
| 114 | adhesion of symbiont to host (GO:0044406) | 3.39827857 |
| 115 | virion attachment to host cell (GO:0019062) | 3.29769698 |
| 116 | adhesion of symbiont to host cell (GO:0044650) | 3.29769698 |
| 117 | negative regulation of hemostasis (GO:1900047) | 3.25362870 |
| 118 | negative regulation of blood coagulation (GO:0030195) | 3.25362870 |
| 119 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.22325126 |
| 120 | membrane lipid catabolic process (GO:0046466) | 3.20765663 |
| 121 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.20225243 |
| 122 | sphingolipid catabolic process (GO:0030149) | 3.20082590 |
| 123 | negative regulation of coagulation (GO:0050819) | 3.19960357 |
| 124 | positive regulation of extracellular matrix organization (GO:1903055) | 3.05669258 |
| 125 | response to thyroid hormone (GO:0097066) | 3.04189121 |
| 126 | low-density lipoprotein particle clearance (GO:0034383) | 3.02848659 |
| 127 | acute-phase response (GO:0006953) | 3.00757032 |
| 128 | keratan sulfate catabolic process (GO:0042340) | 2.91336897 |
| 129 | protein-lipid complex assembly (GO:0065005) | 2.89890356 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 2.86373988 |
| 131 | apoptotic cell clearance (GO:0043277) | 2.82510230 |
| 132 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.79892408 |
| 133 | lipoprotein metabolic process (GO:0042157) | 2.79805413 |
| 134 | negative regulation of wound healing (GO:0061045) | 2.79321433 |
| 135 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.76008283 |
| 136 | fructose metabolic process (GO:0006000) | 2.73642211 |
| 137 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.71744433 |
| 138 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.69243124 |
| 139 | negative regulation of lipid transport (GO:0032369) | 2.68155867 |
| 140 | hyaluronan catabolic process (GO:0030214) | 2.67558326 |
| 141 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67244133 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.66548021 |
| 143 | mannose metabolic process (GO:0006013) | 2.66253349 |
| 144 | pinocytosis (GO:0006907) | 2.66146197 |
| 145 | regulation of mononuclear cell migration (GO:0071675) | 2.65117938 |
| 146 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.63698798 |
| 147 | amyloid precursor protein catabolic process (GO:0042987) | 2.63023026 |
| 148 | positive regulation of cholesterol efflux (GO:0010875) | 2.60689396 |
| 149 | negative regulation of protein activation cascade (GO:2000258) | 2.60348304 |
| 150 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.57246661 |
| 151 | regulation of apoptotic cell clearance (GO:2000425) | 2.56283476 |
| 152 | regulation of sterol transport (GO:0032371) | 2.55894959 |
| 153 | regulation of cholesterol transport (GO:0032374) | 2.55894959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.10046348 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.97317132 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.91776282 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18333904 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.19966130 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.08538753 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.02320296 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06448955 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63758758 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.74187580 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24253351 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16738611 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.05505904 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04853819 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01444441 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6177618 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97539749 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93278207 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93170274 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88290579 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82900439 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82339996 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73173027 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55590340 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51649466 |
| 26 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.45468172 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45050207 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43447145 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43412797 |
| 30 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.42907007 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38518845 |
| 32 | * P68_20966046_ChIP-Seq_HELA_Human | 1.37305218 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37239743 |
| 34 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35156804 |
| 35 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33797698 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31109269 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29167354 |
| 38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29060785 |
| 39 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28216716 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26190019 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24019079 |
| 42 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23350368 |
| 43 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21924676 |
| 44 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21918775 |
| 45 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17288663 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15472432 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15301339 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15201799 |
| 49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15069136 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14272478 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13927524 |
| 52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13443178 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12394230 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10242281 |
| 55 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.09907744 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09611834 |
| 57 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08580957 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07422699 |
| 59 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06836343 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06426501 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05653602 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05514539 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05229072 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04410650 |
| 65 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03030824 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02897188 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02714547 |
| 68 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01765487 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01004923 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99913455 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99595184 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99477097 |
| 73 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98552137 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98450341 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97982056 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97016900 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95320011 |
| 78 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95247830 |
| 79 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94806125 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94160886 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93318464 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92897433 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92897433 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92675762 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89438982 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88823658 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87706737 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87269819 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84605365 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84293501 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84213789 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84180154 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83546792 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82864272 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82053067 |
| 96 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79092682 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78783813 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.74760407 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73677239 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72027168 |
| 101 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70244883 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69828504 |
| 103 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67457818 |
| 104 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67086747 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65996763 |
| 106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.65070374 |
| 107 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.65014494 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.62357513 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61382812 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60805888 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60565913 |
| 112 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60556425 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60340678 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59922177 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.59872355 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59795302 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.59497626 |
| 118 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.59065466 |
| 119 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58958099 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58913069 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57968301 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.55676103 |
| 123 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.54871416 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54307523 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52761169 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52301155 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51499845 |
| 128 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.51333706 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.51235794 |
| 130 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50681595 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.50282570 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.50282570 |
| 133 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50226549 |
| 134 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49426714 |
| 135 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49267469 |
| 136 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48604515 |
| 137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.48603880 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48436347 |
| 139 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48408435 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48213085 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47103614 |
| 142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46622328 |
| 143 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.45856438 |
| 144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.45289352 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45000375 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.44786518 |
| 147 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.44457788 |
| 148 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.44153113 |
| 149 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43436724 |
| 150 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42880769 |
| 151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.42843314 |
| 152 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.41683981 |
| 153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.41673452 |
| 154 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.41403362 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41178559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.93807184 |
| 2 | MP0005360_urolithiasis | 7.19533422 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15439041 |
| 4 | * MP0005365_abnormal_bile_salt | 5.80288536 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.89025289 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.17801221 |
| 7 | MP0003252_abnormal_bile_duct | 3.75240551 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54133498 |
| 9 | MP0009840_abnormal_foam_cell | 3.32726234 |
| 10 | MP0005083_abnormal_biliary_tract | 2.98823929 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.70714396 |
| 12 | MP0003195_calcinosis | 2.66665199 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.62023331 |
| 14 | MP0005332_abnormal_amino_acid | 2.58465867 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.51053890 |
| 16 | * MP0001666_abnormal_nutrient_absorption | 2.37180064 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.15994296 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.05486429 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.05142285 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.01110667 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.00036400 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.86966343 |
| 23 | MP0003868_abnormal_feces_composition | 1.83323801 |
| 24 | MP0000343_altered_response_to | 1.78195380 |
| 25 | MP0001764_abnormal_homeostasis | 1.76365671 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60622414 |
| 27 | MP0009697_abnormal_copulation | 1.58256596 |
| 28 | MP0003186_abnormal_redox_activity | 1.48239618 |
| 29 | MP0003011_delayed_dark_adaptation | 1.44830712 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.42579210 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.41562293 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.40686274 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.37848057 |
| 34 | MP0005451_abnormal_body_composition | 1.36523558 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.31623971 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.26594487 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.25613241 |
| 38 | MP0000598_abnormal_liver_morphology | 1.24474947 |
| 39 | MP0002254_reproductive_system_inflammat | 1.22045432 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.21934281 |
| 41 | MP0005023_abnormal_wound_healing | 1.20625386 |
| 42 | MP0006054_spinal_hemorrhage | 1.18024059 |
| 43 | MP0005647_abnormal_sex_gland | 1.16868372 |
| 44 | MP0009764_decreased_sensitivity_to | 1.15001690 |
| 45 | MP0003279_aneurysm | 1.12569176 |
| 46 | MP0005164_abnormal_response_to | 1.11019255 |
| 47 | MP0009763_increased_sensitivity_to | 1.10233426 |
| 48 | MP0008469_abnormal_protein_level | 1.07345059 |
| 49 | MP0001958_emphysema | 1.07145761 |
| 50 | MP0003724_increased_susceptibility_to | 1.05387439 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.04732819 |
| 52 | MP0001542_abnormal_bone_strength | 1.04586672 |
| 53 | MP0000604_amyloidosis | 1.03983530 |
| 54 | MP0004272_abnormal_basement_membrane | 1.03403629 |
| 55 | MP0000858_altered_metastatic_potential | 1.02888164 |
| 56 | MP0005165_increased_susceptibility_to | 0.97329391 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 0.96304714 |
| 58 | MP0005670_abnormal_white_adipose | 0.95752662 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 0.93868995 |
| 60 | MP0003303_peritoneal_inflammation | 0.92132555 |
| 61 | MP0003566_abnormal_cell_adhesion | 0.91420576 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.91022573 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.90502798 |
| 64 | MP0002896_abnormal_bone_mineralization | 0.89547724 |
| 65 | * MP0009642_abnormal_blood_homeostasis | 0.89160946 |
| 66 | MP0004510_myositis | 0.87785645 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.87782975 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.87782975 |
| 69 | MP0000371_diluted_coat_color | 0.87717495 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.87467579 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.84601378 |
| 72 | MP0005408_hypopigmentation | 0.83478069 |
| 73 | MP0004858_abnormal_nervous_system | 0.83399540 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.83334318 |
| 75 | MP0005410_abnormal_fertilization | 0.79734365 |
| 76 | MP0004947_skin_inflammation | 0.79657770 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.79631362 |
| 78 | MP0003879_abnormal_hair_cell | 0.78312197 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.76895194 |
| 80 | MP0002971_abnormal_brown_adipose | 0.76831078 |
| 81 | MP0003091_abnormal_cell_migration | 0.76209312 |
| 82 | MP0004130_abnormal_muscle_cell | 0.75428070 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.75198902 |
| 84 | MP0003448_altered_tumor_morphology | 0.74727672 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.74460212 |
| 86 | MP0003436_decreased_susceptibility_to | 0.74282277 |
| 87 | MP0004233_abnormal_muscle_weight | 0.73924288 |
| 88 | MP0005334_abnormal_fat_pad | 0.73770755 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.72456455 |
| 90 | MP0008260_abnormal_autophagy | 0.72084305 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.71964135 |
| 92 | MP0009278_abnormal_bone_marrow | 0.71286667 |
| 93 | MP0005387_immune_system_phenotype | 0.70946957 |
| 94 | MP0001790_abnormal_immune_system | 0.70946957 |
| 95 | MP0002933_joint_inflammation | 0.70603781 |
| 96 | MP0001853_heart_inflammation | 0.68707515 |
| 97 | MP0005266_abnormal_metabolism | 0.68049873 |
| 98 | MP0005390_skeleton_phenotype | 0.66931251 |
| 99 | MP0003795_abnormal_bone_structure | 0.66099015 |
| 100 | MP0005535_abnormal_body_temperature | 0.64798632 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 0.64228128 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.64137604 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.63683972 |
| 104 | MP0005275_abnormal_skin_tensile | 0.62947056 |
| 105 | MP0001661_extended_life_span | 0.61064124 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.58859469 |
| 107 | MP0003690_abnormal_glial_cell | 0.58802948 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.58492140 |
| 109 | MP0001756_abnormal_urination | 0.57549052 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.57220926 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.56138758 |
| 112 | MP0003075_altered_response_to | 0.55817771 |
| 113 | MP0005448_abnormal_energy_balance | 0.55749951 |
| 114 | MP0008873_increased_physiological_sensi | 0.51912717 |
| 115 | MP0002928_abnormal_bile_duct | 0.51266731 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.50865641 |
| 117 | MP0004381_abnormal_hair_follicle | 0.49249083 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.48892435 |
| 119 | MP0009785_altered_susceptibility_to | 0.48422318 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.47609365 |
| 121 | MP0009379_abnormal_foot_pigmentation | 0.46848906 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.45189206 |
| 123 | MP0005166_decreased_susceptibility_to | 0.45155900 |
| 124 | MP0000249_abnormal_blood_vessel | 0.44443712 |
| 125 | MP0005075_abnormal_melanosome_morpholog | 0.43937140 |
| 126 | MP0006082_CNS_inflammation | 0.43327450 |
| 127 | MP0003329_amyloid_beta_deposits | 0.43083166 |
| 128 | MP0004147_increased_porphyrin_level | 0.43063701 |
| 129 | MP0002132_abnormal_respiratory_system | 0.43026314 |
| 130 | MP0009115_abnormal_fat_cell | 0.42578167 |
| 131 | MP0003718_maternal_effect | 0.42463556 |
| 132 | MP0005395_other_phenotype | 0.42090464 |
| 133 | MP0005025_abnormal_response_to | 0.41394701 |
| 134 | MP0002419_abnormal_innate_immunity | 0.41308222 |
| 135 | MP0001835_abnormal_antigen_presentation | 0.39803733 |
| 136 | MP0002970_abnormal_white_adipose | 0.39479550 |
| 137 | MP0003953_abnormal_hormone_level | 0.39003712 |
| 138 | MP0008874_decreased_physiological_sensi | 0.38101097 |
| 139 | MP0000685_abnormal_immune_system | 0.37728159 |
| 140 | MP0009053_abnormal_anal_canal | 0.36241060 |
| 141 | MP0001243_abnormal_dermal_layer | 0.36017254 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.34830285 |
| 143 | MP0002060_abnormal_skin_morphology | 0.34033510 |
| 144 | MP0002796_impaired_skin_barrier | 0.33299436 |
| 145 | MP0001881_abnormal_mammary_gland | 0.33204245 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.33178826 |
| 147 | MP0004883_abnormal_blood_vessel | 0.33130221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23534184 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.03613486 |
| 3 | * Intrahepatic cholestasis (HP:0001406) | 6.79247863 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.56356044 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.56356044 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 6.56356044 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.47042081 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.38694331 |
| 9 | Xanthomatosis (HP:0000991) | 6.12610260 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 6.03058551 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.42030695 |
| 12 | Complement deficiency (HP:0004431) | 5.36612113 |
| 13 | Joint hemorrhage (HP:0005261) | 4.76603281 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.64440228 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.53959469 |
| 16 | Hyperammonemia (HP:0001987) | 4.48731512 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.48520626 |
| 18 | Epidermoid cyst (HP:0200040) | 4.33417570 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.22623411 |
| 20 | Dysostosis multiplex (HP:0000943) | 4.22420978 |
| 21 | Hyperglycinemia (HP:0002154) | 4.18139441 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.11362938 |
| 23 | Ketosis (HP:0001946) | 4.11311016 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.07515808 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.07515808 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.07515808 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04469224 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.99673082 |
| 29 | Abnormality of complement system (HP:0005339) | 3.96084014 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.94763050 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.94763050 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.94179141 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.93699862 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.93457706 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91563392 |
| 36 | Hyperglycinuria (HP:0003108) | 3.81314246 |
| 37 | * Fat malabsorption (HP:0002630) | 3.75899858 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.75793976 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75793976 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.71398733 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.68544477 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.66665277 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61256538 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49762141 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45821775 |
| 46 | Vertebral compression fractures (HP:0002953) | 3.26218849 |
| 47 | * Hyperbilirubinemia (HP:0002904) | 3.20042890 |
| 48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.13830296 |
| 49 | Spontaneous abortion (HP:0005268) | 3.10984422 |
| 50 | Delayed CNS myelination (HP:0002188) | 3.03985859 |
| 51 | Myocardial infarction (HP:0001658) | 3.01962555 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.96803622 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.94633671 |
| 54 | Premature rupture of membranes (HP:0001788) | 2.94371324 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93856235 |
| 56 | Axonal loss (HP:0003447) | 2.93231145 |
| 57 | Ketoacidosis (HP:0001993) | 2.91569641 |
| 58 | Loss of speech (HP:0002371) | 2.88241155 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.83531440 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.82988761 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.77680363 |
| 62 | Metabolic acidosis (HP:0001942) | 2.75214461 |
| 63 | Acanthocytosis (HP:0001927) | 2.74546970 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.73170324 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73170324 |
| 66 | * Steatorrhea (HP:0002570) | 2.66077374 |
| 67 | Skin nodule (HP:0200036) | 2.64778159 |
| 68 | Purpura (HP:0000979) | 2.62946819 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61152577 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.60156083 |
| 71 | Gingival bleeding (HP:0000225) | 2.54507117 |
| 72 | Lethargy (HP:0001254) | 2.54187237 |
| 73 | Prolonged neonatal jaundice (HP:0006579) | 2.53620069 |
| 74 | Joint stiffness (HP:0001387) | 2.50610620 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.47025885 |
| 76 | Spastic diplegia (HP:0001264) | 2.44913003 |
| 77 | Glomerulonephritis (HP:0000099) | 2.43047112 |
| 78 | Amyloidosis (HP:0011034) | 2.42780912 |
| 79 | Vascular calcification (HP:0004934) | 2.41078230 |
| 80 | Menorrhagia (HP:0000132) | 2.38676813 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.35790238 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.33451112 |
| 83 | Thin bony cortex (HP:0002753) | 2.33055061 |
| 84 | Nuclear cataract (HP:0100018) | 2.32992441 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.31514232 |
| 86 | Abnormality of macrophages (HP:0004311) | 2.31281010 |
| 87 | Cervical subluxation (HP:0003308) | 2.30387725 |
| 88 | Cholelithiasis (HP:0001081) | 2.29738086 |
| 89 | Mitral stenosis (HP:0001718) | 2.28771967 |
| 90 | Cerebral edema (HP:0002181) | 2.28749930 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.27993937 |
| 92 | Protrusio acetabuli (HP:0003179) | 2.27683064 |
| 93 | Esophageal varix (HP:0002040) | 2.26660116 |
| 94 | Cholecystitis (HP:0001082) | 2.25249308 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.25249308 |
| 96 | Thrombophlebitis (HP:0004418) | 2.24941478 |
| 97 | Retinal atrophy (HP:0001105) | 2.24872103 |
| 98 | Pancreatitis (HP:0001733) | 2.23412988 |
| 99 | Metaphyseal irregularity (HP:0003025) | 2.23300480 |
| 100 | Brushfield spots (HP:0001088) | 2.22265915 |
| 101 | Gout (HP:0001997) | 2.22158274 |
| 102 | Irritability (HP:0000737) | 2.20503173 |
| 103 | Protuberant abdomen (HP:0001538) | 2.19460715 |
| 104 | Late onset (HP:0003584) | 2.15950643 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 2.15652380 |
| 106 | Malnutrition (HP:0004395) | 2.15134074 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.13318758 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 2.13061688 |
| 109 | Cardiomegaly (HP:0001640) | 2.12457324 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.12394438 |
| 111 | Opisthotonus (HP:0002179) | 2.11182287 |
| 112 | Poikilocytosis (HP:0004447) | 2.10552539 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 2.08044689 |
| 114 | Mesangial abnormality (HP:0001966) | 2.07764906 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.07004473 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.06806225 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05271461 |
| 118 | Vomiting (HP:0002013) | 2.05232043 |
| 119 | Distal lower limb muscle weakness (HP:0009053) | 1.95793233 |
| 120 | Renal cortical cysts (HP:0000803) | 1.92909884 |
| 121 | Enlarged kidneys (HP:0000105) | 1.92854272 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 1.92476393 |
| 123 | Distal upper limb amyotrophy (HP:0007149) | 1.92476203 |
| 124 | Upper limb amyotrophy (HP:0009129) | 1.92476203 |
| 125 | Hypertriglyceridemia (HP:0002155) | 1.91265679 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88741852 |
| 127 | * Elevated hepatic transaminases (HP:0002910) | 1.88014205 |
| 128 | Neoplasm of head and neck (HP:0012288) | 1.87469816 |
| 129 | Esophageal neoplasm (HP:0100751) | 1.87469816 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.85695036 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.85525846 |
| 132 | * Neonatal onset (HP:0003623) | 1.84536616 |
| 133 | Epistaxis (HP:0000421) | 1.84220568 |
| 134 | Bone pain (HP:0002653) | 1.84090444 |
| 135 | Abnormality of proline metabolism (HP:0010907) | 1.82239519 |
| 136 | Hydroxyprolinuria (HP:0003080) | 1.82239519 |
| 137 | Increased serum ferritin (HP:0003281) | 1.81491027 |
| 138 | Nonimmune hydrops fetalis (HP:0001790) | 1.79687938 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77293950 |
| 140 | Hand muscle atrophy (HP:0009130) | 1.75486657 |
| 141 | Nephritis (HP:0000123) | 1.75325250 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.74659847 |
| 143 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74659847 |
| 144 | Increased mean platelet volume (HP:0011877) | 1.74052427 |
| 145 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74008070 |
| 146 | Polycythemia (HP:0001901) | 1.73857009 |
| 147 | Rickets (HP:0002748) | 1.73193222 |
| 148 | Pathologic fracture (HP:0002756) | 1.72177058 |
| 149 | Cerebral inclusion bodies (HP:0100314) | 1.71793032 |
| 150 | Hypophosphatemia (HP:0002148) | 1.70568293 |
| 151 | Multiple lipomas (HP:0001012) | 1.66806893 |
| 152 | Upper motor neuron abnormality (HP:0002127) | 1.65497365 |
| 153 | Abnormality of the periventricular white matter (HP:0002518) | 1.64605945 |
| 154 | Abdominal distention (HP:0003270) | 1.63348837 |
| 155 | Hepatosplenomegaly (HP:0001433) | 1.61996428 |
| 156 | Elevated alkaline phosphatase (HP:0003155) | 1.61769799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.61413153 |
| 2 | ERN1 | 4.41282101 |
| 3 | FGFR4 | 4.12814545 |
| 4 | SIK1 | 3.92143674 |
| 5 | TAOK3 | 3.60642098 |
| 6 | TESK1 | 3.12655407 |
| 7 | EPHA2 | 3.09416688 |
| 8 | INSRR | 2.58195142 |
| 9 | LIMK1 | 2.41875404 |
| 10 | TESK2 | 2.33436189 |
| 11 | FLT3 | 2.30131414 |
| 12 | ERBB4 | 2.27281647 |
| 13 | TYK2 | 2.24025170 |
| 14 | KDR | 2.15932226 |
| 15 | DDR2 | 2.13574437 |
| 16 | TIE1 | 2.12304273 |
| 17 | MST1R | 1.90932749 |
| 18 | MAPK11 | 1.90094847 |
| 19 | PDK2 | 1.89386456 |
| 20 | PIK3CG | 1.81895478 |
| 21 | TBK1 | 1.81157193 |
| 22 | PKN2 | 1.74235783 |
| 23 | MAP2K3 | 1.68672651 |
| 24 | TGFBR2 | 1.66757859 |
| 25 | ARAF | 1.62294587 |
| 26 | MAP2K4 | 1.55463588 |
| 27 | NEK9 | 1.53774570 |
| 28 | PAK4 | 1.52134065 |
| 29 | LMTK2 | 1.48777816 |
| 30 | ABL2 | 1.45166457 |
| 31 | TRIB3 | 1.44662414 |
| 32 | KIT | 1.38338462 |
| 33 | JAK2 | 1.34214208 |
| 34 | ICK | 1.27432977 |
| 35 | PTK6 | 1.24810586 |
| 36 | MAPK15 | 1.22967248 |
| 37 | PRKAA2 | 1.14859754 |
| 38 | MAP3K14 | 1.13866951 |
| 39 | JAK1 | 1.13768188 |
| 40 | IKBKE | 1.13123193 |
| 41 | GRK7 | 1.11913477 |
| 42 | IRAK3 | 1.11218250 |
| 43 | MAPK4 | 1.07529829 |
| 44 | CSF1R | 1.06983666 |
| 45 | MUSK | 1.02587624 |
| 46 | PDGFRA | 1.01812199 |
| 47 | FRK | 1.00481444 |
| 48 | CAMK1D | 1.00242750 |
| 49 | MAP4K1 | 0.99963894 |
| 50 | MAP3K7 | 0.99520356 |
| 51 | MOS | 0.98923298 |
| 52 | MAP3K3 | 0.96871390 |
| 53 | TGFBR1 | 0.93164705 |
| 54 | PINK1 | 0.92007429 |
| 55 | CDC42BPA | 0.91548383 |
| 56 | ADRBK2 | 0.91472320 |
| 57 | STK16 | 0.85945690 |
| 58 | ERBB2 | 0.84973810 |
| 59 | EPHB1 | 0.84817271 |
| 60 | EPHB2 | 0.83178351 |
| 61 | CDK6 | 0.82915018 |
| 62 | DAPK2 | 0.82595621 |
| 63 | JAK3 | 0.79695674 |
| 64 | LATS1 | 0.78503128 |
| 65 | MAP3K11 | 0.78340825 |
| 66 | GRK6 | 0.76917104 |
| 67 | ACVR1B | 0.75912235 |
| 68 | FGFR2 | 0.75192844 |
| 69 | MAPK12 | 0.74210179 |
| 70 | MAP2K6 | 0.73668557 |
| 71 | BMX | 0.73598786 |
| 72 | CAMKK2 | 0.71385839 |
| 73 | NME2 | 0.71088293 |
| 74 | TEC | 0.70407047 |
| 75 | EPHA3 | 0.69997396 |
| 76 | BTK | 0.69376372 |
| 77 | FER | 0.67567394 |
| 78 | DYRK1B | 0.67247968 |
| 79 | RPS6KA2 | 0.67096948 |
| 80 | MAP3K10 | 0.64001227 |
| 81 | MAP3K6 | 0.63888126 |
| 82 | MAP3K12 | 0.62902010 |
| 83 | CSK | 0.61871712 |
| 84 | MAPKAPK3 | 0.61436507 |
| 85 | MAPKAPK2 | 0.59945397 |
| 86 | TRPM7 | 0.57905775 |
| 87 | MET | 0.57277175 |
| 88 | PRKACG | 0.56883883 |
| 89 | RIPK1 | 0.56580117 |
| 90 | IKBKB | 0.55531839 |
| 91 | MAP3K2 | 0.54901042 |
| 92 | ZAP70 | 0.54253711 |
| 93 | GRK1 | 0.54159072 |
| 94 | PIM2 | 0.53702401 |
| 95 | PRKCZ | 0.51235365 |
| 96 | FGFR3 | 0.50957063 |
| 97 | PRKD2 | 0.50621756 |
| 98 | TTN | 0.50512442 |
| 99 | MYLK | 0.50334519 |
| 100 | MAP3K13 | 0.48366449 |
| 101 | PRKAA1 | 0.48037093 |
| 102 | GSK3A | 0.47864772 |
| 103 | ILK | 0.46897797 |
| 104 | SMG1 | 0.46219188 |
| 105 | IGF1R | 0.45929830 |
| 106 | PDK1 | 0.45840605 |
| 107 | MATK | 0.45559770 |
| 108 | CDK4 | 0.43770309 |
| 109 | STK38 | 0.42957144 |
| 110 | VRK2 | 0.42899892 |
| 111 | HIPK2 | 0.42735672 |
| 112 | CAMK2G | 0.41893431 |
| 113 | PRKCI | 0.41819608 |
| 114 | PRPF4B | 0.41183949 |
| 115 | DAPK1 | 0.40748994 |
| 116 | EIF2AK1 | 0.40417289 |
| 117 | PAK2 | 0.38917277 |
| 118 | MTOR | 0.38560411 |
| 119 | PAK1 | 0.37590631 |
| 120 | MAP3K1 | 0.35279644 |
| 121 | MAP3K8 | 0.34523194 |
| 122 | MAP2K2 | 0.34294790 |
| 123 | BLK | 0.33975550 |
| 124 | MAPK7 | 0.33199876 |
| 125 | LYN | 0.32999808 |
| 126 | PTK2 | 0.31542608 |
| 127 | CSNK1G1 | 0.31225674 |
| 128 | IRAK1 | 0.31056048 |
| 129 | CAMK2D | 0.30416984 |
| 130 | PRKCQ | 0.29717675 |
| 131 | NLK | 0.29680278 |
| 132 | MAP3K5 | 0.29635235 |
| 133 | DAPK3 | 0.29400269 |
| 134 | IRAK2 | 0.29088778 |
| 135 | PRKG2 | 0.29054085 |
| 136 | ABL1 | 0.29041785 |
| 137 | EGFR | 0.28782982 |
| 138 | MAPK3 | 0.28587200 |
| 139 | IRAK4 | 0.28348021 |
| 140 | SRC | 0.28038009 |
| 141 | PDPK1 | 0.27735740 |
| 142 | RPS6KC1 | 0.27625547 |
| 143 | RPS6KL1 | 0.27625547 |
| 144 | LRRK2 | 0.27386093 |
| 145 | MAP2K1 | 0.27041042 |
| 146 | PIM1 | 0.26646170 |
| 147 | TAOK2 | 0.26535119 |
| 148 | CHUK | 0.26093935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43790316 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51753833 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30551666 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07154419 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92471524 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83282714 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68122133 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64439597 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58590653 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55871161 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52098059 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45480588 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28969081 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.15593355 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10248192 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01471300 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98210435 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96461288 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92338947 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90241142 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88542801 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88180637 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86670984 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85681960 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82634366 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82397794 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74467624 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68756400 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.67294395 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67262407 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64167196 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.60487507 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59757117 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47434340 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45351008 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45234280 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.43211246 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40902805 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40429813 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37903242 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34404513 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32075103 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32033502 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28605026 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.28412813 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16981723 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16233730 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12951393 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11774909 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10980572 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10702434 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05155201 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03483790 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01152400 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99486615 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99026132 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.97250008 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96037130 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93586971 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93086481 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91090113 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89397848 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84609894 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.84237382 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78283778 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76895861 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.75890487 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69609580 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68994515 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67338150 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67176514 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61946820 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56861721 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.53929914 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53421600 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53376947 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53345855 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52442691 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49402468 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48851960 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48519419 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.42307387 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39848498 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35061153 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31738808 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.30949107 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30899488 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.30073185 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.27405338 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26472068 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26274998 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26184067 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.25807392 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25187676 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24889639 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.23315105 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.21825117 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.20506241 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15596135 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07541032 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07419732 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06084030 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01747635 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | -0.2241654 |
| 105 | Malaria_Homo sapiens_hsa05144 | -0.1933701 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1761657 |
| 107 | Lysosome_Homo sapiens_hsa04142 | -0.1744291 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1703494 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1588423 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1422753 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1398514 |
| 112 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1335482 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1302875 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1297370 |
| 115 | Pertussis_Homo sapiens_hsa05133 | -0.1252848 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1165652 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1154788 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1053624 |
| 119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0913614 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0607383 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0407185 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0168685 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0089499 |

